{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:10:04Z","timestamp":1779117004209,"version":"3.51.4"},"reference-count":54,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Setpoint Medical"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2662122","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:45:36Z","timestamp":1778683536000},"page":"1462-1473","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness of vagus nerve-mediated neuroimmune modulation for the treatment of moderate-to-severe rheumatoid arthritis"],"prefix":"10.1080","volume":"29","author":[{"given":"Ellen L.","family":"Air","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Henry Ford Health","place":["Detroit, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Ryschon","sequence":"additional","affiliation":[{"name":"Wing Tech Inc.","place":["Menlo Park, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua M.","family":"Rosenow","sequence":"additional","affiliation":[{"name":"Neurosurgery, Neurology and Physical Medicine and Rehabilitation, Northwestern Medicine","place":["Chicago, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail M.","family":"Garner","sequence":"additional","affiliation":[{"name":"Wing Tech Inc.","place":["Menlo Park, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Levin","sequence":"additional","affiliation":[{"name":"Bay Area Rheumatology","place":["Clearwater, USA"]},{"name":"Department of Medicine, University of South Florida","place":["Tampa, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Konrad","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, West Virginia University","place":["Morgantown, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan B.","family":"Pietzsch","sequence":"additional","affiliation":[{"name":"Wing Tech Inc.","place":["Menlo Park, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2025.102036"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2011.17.s9-b.S03"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10153289"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3726-1"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-18966-0"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16162966"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903422307"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11728"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rky005"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41752"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356"},{"key":"e_1_3_6_13_1","unstructured":"MEDPAC. Health Care Spending and the Medicare Program. 2025 [cited 2025 Oct 16]. Available from: https:\/\/www.medpac.gov\/wp-content\/uploads\/2025\/07\/July2025_MedPAC_DataBook_SEC.pdf."},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41138"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.08.002"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04727-7"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11646"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04114-7"},{"key":"e_1_3_6_19_1","unstructured":"SetPoint Medical Receives FDA Approval for Novel Neuroimmune Modulation Therapy for Rheumatoid Arthritis: Setpoint Medical. 2025 [cited 2025 Sep 19]. Available from: https:\/\/setpointmedical.com\/setpoint-medical-receives-fda-approval-for-novel-neuroimmune-modulation-therapy-for-rheumatoid-arthritis\/."},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000004673"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/ner.12474"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25407"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead106"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.3171\/2016.1.PEDS15534"},{"key":"e_1_3_6_26_1","unstructured":"Institute for Clinical and Economic Review. Targeted immune modulators for rheumatoid arthritis: effectiveness & value. 2017."},{"key":"e_1_3_6_27_1","volume-title":"CY 2025 Medicare Hosptial outpatient prospective payment system and ambulatory surgical center payment system final rule","author":"Centers for Medicare & Medicaid Services","year":"2024","unstructured":"Centers for Medicare & Medicaid Services. CY 2025 Medicare Hosptial outpatient prospective payment system and ambulatory surgical center payment system final rule. Baltimore, MD CMS; 2024 [cited 2025 Aug 1]."},{"key":"e_1_3_6_28_1","unstructured":"US Food and Drug Administration. Drugs@FDA: FDA-Approved Drugs [cited 2025 Aug 8]. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=browseByLetter.page&productLetter=A&ai=0."},{"key":"e_1_3_6_29_1","unstructured":"US Department of Veterans Affairs. Office of Procurement Acquisition and Logistics (OPAL) Pharmaceutical Prices 2025 [cited 2025 Apr 1]. Available from: https:\/\/www.va.gov\/opal\/nac\/fss\/pharmPrices.asp."},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780190492939.001.0001"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.016"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11602"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00357-1"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00203-w"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.4.344"},{"key":"e_1_3_6_36_1","unstructured":"Center for Medicare and Medicaid Services. Medicare Part D drug spending dashboard 2025 [cited 2026 Jan 15]. Available from: https:\/\/data.cms.gov\/tools\/medicare-part-d-drug-spending-dashboard."},{"key":"e_1_3_6_37_1","unstructured":"Bureau of Labor Statistics. Consumer Price Index for US medical care all urban consumers. 2025. [cited 2025 Sep 22]. Available from: https:\/\/data.bls.gov\/pdq\/SurveyOutputServlet."},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/174591"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9001000308"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07245-3"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1470519"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1497957"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23538"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.26.8.1039"},{"issue":"1","key":"e_1_3_6_45_1","first-page":"42","article-title":"Comparing healthcare costs associated with oral and subcutaneous methotrexate or biologic therapy for rheumatoid arthritis in the United States","volume":"10","author":"Lee J","year":"2017","unstructured":"Lee J, Pelkey R, Gubitosa J, et al. Comparing healthcare costs associated with oral and subcutaneous methotrexate or biologic therapy for rheumatoid arthritis in the United States. Am Health Drug Benefits. 2017;10(1):42\u201349.","journal-title":"Am Health Drug Benefits"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1099538"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01730-w"},{"issue":"1","key":"e_1_3_6_48_1","first-page":"27","article-title":"Biologic disease-modifying antirheumatic drugs in a national, privately insured population: utilization, expenditures, and price trends","volume":"10","author":"Atzinger CB","year":"2017","unstructured":"Atzinger CB, Guo JJ. Biologic disease-modifying antirheumatic drugs in a national, privately insured population: utilization, expenditures, and price trends. Am Health Drug Benefits. 2017;10(1):27.","journal-title":"Am Health Drug Benefits"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-022-00473-6"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39079"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/10600280251327434"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4932"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2025.03.008"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-024-01731-w"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-025-00798-y"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2662122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:46:07Z","timestamp":1779115567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2662122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2662122"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2662122","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}